Opens in a new tab or window For patients with HIV and atrial fibrillation, this study found that apixaban was associated with less bleeding when compared with warfarin and rivaroxaban.
Credit: Shutterstock / BioFoto. Taho Pharmaceuticals’s apixaban-based oral dissolving strips were discovered to be a bioequivalent of Pfizer and Bristol-Myers Squibb’s (BMS) Eliquis in a Phase II ...
A SUBGROUP analysis of the ARTESiA trial suggests that apixaban provides a significant reduction in stroke or systemic embolism in people with subclinical atrial fibrillation and a history of stroke ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results